A.S.P.E.N. Clinical Nutrition Week 2016 Poster on Lactobacillus salivarius UCC118 strain for Symptom Relief in SIBO
Poster presented by Dr. Gail Cresci, Cleveland Clinic, at ASPEN 2016
Daily consumption of the probiotic strain Lactobacillus salivarius UCC118 appeared to help relieve severity of gastrointestinal (GI) symptoms associated with small intestinal bacterial overgrowth (SIBO), according to a pilot quality improvement study.
The study participants (n=29) were recruited from patients who presented to the Cleveland Clinic Center for Gut Rehabilitation and Transplantation outpatient clinic (Cleveland, OH) in 2015. Participants were provided and instructed to orally consume the probiotic supplement (108 CFU/capsule daily) for 90 days in addition to standard therapy. GI symptoms consistent with SIBO, such as diarrhea, bloating, foul stool, flatulence, and stool characteristics, were assessed at baseline and at 30, 60, and 90 days. The data showed that daily consumption of the probiotic strain Lactobacillus salivarius UCC118 was effective in relieving severity of several GI symptoms and negating or delaying the need for antibiotic therapy.
These results were presented as a scientific poster at Clinical Nutrition Week 2016 hosted by the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N) on Jan 16-19; Austin, TX .
 Cresci G, Izzo K, Furman A, Melnick L, Shantnawei A. Effects of Lactobacillus salivarius UCC118 in reducing symptoms of small intestinal bacterial overgrowth [abstract]. (http://journals.sagepub.com/pb-assets/cmscontent/PEN/CNW16_Monday_Poster_Abstracts_revised.pdf)